Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment

NCT ID: NCT02283996

Last Updated: 2025-10-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE4

Total Enrollment

260 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to identify individuals 18 or older who have diagnostic presentation of adhesive capsulitis and randomize them into two arms, distinguished by use of physical therapy and steroid injections compared with steroid injections followed by watchful waiting. This prospective study will be used to determine whether there is a significant impact on patient outcome and whether the additional financial burden is justified. There are no experimental interventions for this study. The use of physical therapy, oral and parenteral corticosteroids, and watchful waiting are offered following the standard of care for adhesive capsulitis. Our hypothesis is that patients will not have a significant difference in outcome between the two study arms. One group will undergo regular physical therapy with corticosteroid injections (Arm 1) and the other will have steroid injections during the inflammatory phase only and then be regularly observed (Arm 2). We also hypothesize there will be a significant financial burden associated with the PT arm that is not justified with the possibility of increased symptom reports in that arm.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A. Objectives

The purpose of this study is to identify individuals 18 or older who have diagnostic presentation of adhesive capsulitis and randomize them into two arms, distinguished by use of physical therapy and steroid injections compared with steroid injections followed by watchful waiting. This prospective study will be used to determine whether there is a significant impact on patient outcome and whether the additional financial burden is justified. The standard of care calls for initial non-operative therapy consisting of NSAIDs, watchful waiting, and oral and parenteral corticosteroid administration with consideration for operative therapy after 6 months of failed conservative therapy. We would like to enroll patients who are willing to be randomized and postpone operative therapy for a period of up to one year during which we would have scheduled follow up visits at regular intervals. There are no experimental interventions for this study. The use of physical therapy, oral and parenteral corticosteroids, and watchful waiting are offered following the standard of care for adhesive capsulitis.

B. Background Adhesive capsulitis, also known as "frozen shoulder" is a common orthopedic condition affecting 2-5% of the general population13. As defined by the American Academy of Orthopedic Surgeons, it is a self-limiting condition resulting from any inflammatory process about the shoulder in which capsular scar tissue is produced, resulting in pain and limited range of motion.

The majority of shoulder function comes from the interactions of the glenohumeral ligament complex, the rotator cuff complex, and the articulating bones. The superior glenohumeral ligament is important in stabilization of the glenohumeral joint in adduction and external rotation. The middle glenohumeral ligament is an important stabilizing structure in the positions of adduction and external rotation and abduction up to 45° in external rotation. The resistance, and therefore tension, of the inferior glenohumeral ligament, which is negligible in positions of neutral adduction and adduction in external rotation, increases in value for angles between 45° and 90°, indicating the important stabilizing function of this ligament in those positions. The rotator cuff is comprised of the tendons of the supraspinatus, infraspinatus, teres minor, and subscapularis muscles1,10.

In this disease state, there is a capsular pattern of shoulder dysfunction which is characterized by slight limitation of medial rotation, moderate limitation of passive abduction, and most importantly, severe limitation of lateral rotation. The finding of lateral rotation limitation or capsular pattern of limitation can be diagnostic in the assessment of AC.

The rotator cuff is comprised of the subscapularis, biceps, supraspinatus, infraspinatus, and teres minor muscles. The subscapularis muscle may be divided into nine bellies. The muscle acts as the main internal rotator of the shoulder joint and provides support against traumatic posterior dislocation. The supraspinatus is the main abductor of the arm until 30° degrees after which the deltoid muscle takes over. It constitutes the posterior margin of the rotator cuff interval. A fusion between the infraspinatus and teres minor tendons is so common that the latter is sometimes considered the inferior belly of the infraspinatus. Hence, the presence of a separate teres minor tendon should be considered a variation. The infraspinatus acts in oppositions of the subscapularis as the main external rotator of the arm and works in conjunction with teres minor in completing this objective. Teres minor also assists with extension of the arm1,10.

Several shoulder scoring systems have been used to measure patient outcomes after surgery and other therapies. These include the The American Shoulder and Elbow Surgeons Standardized Shoulder Assessment (ASES), Disabilities of the Arm, Shoulder, and Hand Questionnaire (DASH), and Constant-Murley Shoulder Outcome Score System. In addition, physical exam findings, patient satisfaction, and return to athletics have been used to further delineate outcomes. Our study will use the ASES, the DASH, and the Constant Score System17.

Stages -

1. \- Freezing (inflammatory): consists of the initial onset of pain and loss of range of motion that can last anywhere between six weeks to nine months7
2. \- Frozen: may show an improvement in pain, but a worsening in range of motion and generally lasts from four to six months7
3. \- Thawing: consists of a resolution of symptoms with partial or full return of function that can take between six months to two years7 The most commonly affected demographic is adults in their fourth to sixth decade of life with a median onset of 55 years old and a high incidence in women than men. The condition generally presents unilaterally with the non-dominant shoulder more commonly affected and a progression to bilateral presentation within 5 years in 6 to 17% of patients.16,18,22¬ The aim of treatment is bimodal with one aspect being the resolution of pain and the other being improving range of motion. Common treatments include NSAIDs, oral corticosteroids, intra-articular corticosteroid injection with and without anesthetic, as well as intracapsular distention with and without corticosteroids.

Corticosteroid injections - A randomized pilot study in 2009 showed that there were clinically significant improvements in all aspects of function and quality of life for those patients undergoing corticosteroid injections, with no statistically significant difference between patients who underwent capsular distension21. The use of injections in the short term has been proven efficacious in the short term in alleviating pain and increasing ROM. The utility of steroids in the long term has been called into question by a 2008 prospective study that showed that the comparison of steroid injections and physical therapy to physical therapy alone yielded no change in end result2.

Short wave diathermy and manipulation under anesthesia (MUA) - Uses radio frequency energy to generate heat in tissues, which has an analgesic effect and reduces muscle spasm and joint stiffness. In one study, short-wave diathermy was showed in randomized control trials to improve outcomes compared to general home exercise16,22.

Physical therapy - Maitland mobilization physiotherapy was observed in a single case design to provide increased quality of life, but no significant objective changes in functional status15. Another prospective outcome study evaluating patients who underwent non-operative treatments showed simple home exercise programs to positive outcomes even in patients who had had previously failed attempts at resolution through intensive physiotherapy15,20.

Watchful waiting - A wait and see approach, which has been shown to improve outcomes over intense physiotherapy in some cases by being favorable in achieving near pain free function within 24 months.

Systematic review in 2012 reviewed nineteen databases in the UK for cost efficacy of various interventions made no significant claims as to which interventions were the most economically advantageous proposing a multi-arm trial comparing high quality conservative management, steroid injection, steroid injection in conjunction with capsular distension, capsular release with MUA16. With growing costs of healthcare and the need to cut down on extraneous interventions, the role of physiotherapy as an adjunctive measure should be thoroughly evaluated.

While there have not been sufficient studies on the cost effectiveness as the aforementioned review suggested, there was one study that addressed the use of physiotherapy following capsular distension21. The conclusions garnered from the study showed that the use of physiotherapy was not cost effective showing no beneficial advantage in improving pain, function, or quality of life5,15,19.

By determining the objective contribution physiotherapy has on the resolution of adhesive capsulitis when compared to operative management, several protocol related inconsistencies can be elaborated upon. The purpose of this study will be to compare and contrast the benefits yielded from the use of adjunctive physiotherapy in patients who undergo conservative management of adhesive capsulitis. This will provide a basis from which to evaluate whether it is an economically effective use of resources. If the impact is found to be negligible in the long term resolution of adhesive capsulitis, this study's results can be used to advocate for alternative therapies that could avoid the cost of innumerable assets.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adhesive Capsulitis Frozen Shoulder Shoulder Frozen

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Physical Therapy with Steroid Injection

Patients will undergo regular physical therapy as defined by the standard of care at Massachusetts General Hospital for Adhesive Capsulitis (Frozen Shoulder). If they are in the inflammatory phase of the condition, they will receive 40 mg of depot methylprednisolone in solution with 2 cc of 1% lidocaine.

Group Type EXPERIMENTAL

Physical Therapy

Intervention Type OTHER

The following link contains the protocol for physical therapy that will be used in the study. There are no other ancillary devices or drugs used in this study aside from the depot methylprednisolone listed under interventions.

Brigham and Women's/Massachusetts General Standard of Care Guidelines for Physical Therapy in Treatment of Adhesive Capsulitis:

http://www.brighamandwomens.org/Patients\_Visitors/pcs/rehabilitationservices/Physical%20Therapy%20Standards%20of%20Care%20and%20Protocols/Shoulder%20-%20Adhesive%20capsulitis.pdf

Depot Methylprednisolone

Intervention Type DRUG

40 mg of depot methylprednisolone in solution with 2 cc of 1% lidocaine

Watchful Waiting with Steroid Injection

Patients will undergo no therapeutic intervention outside of steroid injection. If they are in the inflammatory phase of the condition, they will receive 40 mg of depot methylprednisolone in solution with 2 cc of 1% lidocaine.

Group Type EXPERIMENTAL

Depot Methylprednisolone

Intervention Type DRUG

40 mg of depot methylprednisolone in solution with 2 cc of 1% lidocaine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physical Therapy

The following link contains the protocol for physical therapy that will be used in the study. There are no other ancillary devices or drugs used in this study aside from the depot methylprednisolone listed under interventions.

Brigham and Women's/Massachusetts General Standard of Care Guidelines for Physical Therapy in Treatment of Adhesive Capsulitis:

http://www.brighamandwomens.org/Patients\_Visitors/pcs/rehabilitationservices/Physical%20Therapy%20Standards%20of%20Care%20and%20Protocols/Shoulder%20-%20Adhesive%20capsulitis.pdf

Intervention Type OTHER

Depot Methylprednisolone

40 mg of depot methylprednisolone in solution with 2 cc of 1% lidocaine

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Depo Medrol

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient must be 18 years or older
* Must meet the following definition for adhesive capsulitis as defined by the American Academy of Orthopedic Surgeons: Self-limiting condition resulting from any inflammatory process about the shoulder in which capsular scar tissue is produced, resulting in pain and limited range of motion; also called frozen shoulder
* Must be amenable to randomization into either cohort

Exclusion Criteria

* Non-English speaking patients
* Pregnant women (women of childbearing potential will be advised to undergo regular pregnancy testing)
* Patients who had previously undergone operative therapy for the condition
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Massachusetts General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Scott D Martin

Associate Professor of Orthopedic Surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Scott D Martin, MD

Role: PRINCIPAL_INVESTIGATOR

Massachusetts General Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

MGH, Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Scott D Martin, MD

Role: CONTACT

617-732-5329

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Scott D Martin, MD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Andarawis-Puri N, Kuntz AF, Kim SY, Soslowsky LJ. Effect of anterior supraspinatus tendon partial-thickness tears on infraspinatus tendon strain through a range of joint rotation angles. J Shoulder Elbow Surg. 2010 Jun;19(4):617-23. doi: 10.1016/j.jse.2009.10.003. Epub 2010 Jan 15.

Reference Type BACKGROUND
PMID: 20080051 (View on PubMed)

Bal A, Eksioglu E, Gulec B, Aydog E, Gurcay E, Cakci A. Effectiveness of corticosteroid injection in adhesive capsulitis. Clin Rehabil. 2008 Jun;22(6):503-12. doi: 10.1177/0269215508086179.

Reference Type BACKGROUND
PMID: 18511530 (View on PubMed)

Buchbinder R, Youd JM, Green S, Stein A, Forbes A, Harris A, Bennell K, Bell S, Wright WJ. Efficacy and cost-effectiveness of physiotherapy following glenohumeral joint distension for adhesive capsulitis: a randomized trial. Arthritis Rheum. 2007 Aug 15;57(6):1027-37. doi: 10.1002/art.22892.

Reference Type BACKGROUND
PMID: 17665470 (View on PubMed)

De Carli A, Vadala A, Perugia D, Frate L, Iorio C, Fabbri M, Ferretti A. Shoulder adhesive capsulitis: manipulation and arthroscopic arthrolysis or intra-articular steroid injections? Int Orthop. 2012 Jan;36(1):101-6. doi: 10.1007/s00264-011-1330-7. Epub 2011 Aug 11.

Reference Type BACKGROUND
PMID: 21833684 (View on PubMed)

Griggs SM, Ahn A, Green A. Idiopathic adhesive capsulitis. A prospective functional outcome study of nonoperative treatment. J Bone Joint Surg Am. 2000 Oct;82(10):1398-407.

Reference Type BACKGROUND
PMID: 11057467 (View on PubMed)

Hegedus EJ, Goode A, Campbell S, Morin A, Tamaddoni M, Moorman CT 3rd, Cook C. Physical examination tests of the shoulder: a systematic review with meta-analysis of individual tests. Br J Sports Med. 2008 Feb;42(2):80-92; discussion 92. doi: 10.1136/bjsm.2007.038406. Epub 2007 Aug 24.

Reference Type BACKGROUND
PMID: 17720798 (View on PubMed)

van den Hout WB, Vermeulen HM, Rozing PM, Vliet Vlieland TP. Impact of adhesive capsulitis and economic evaluation of high-grade and low-grade mobilisation techniques. Aust J Physiother. 2005;51(3):141-9. doi: 10.1016/s0004-9514(05)70020-9.

Reference Type BACKGROUND
PMID: 16137239 (View on PubMed)

Jewell DV, Riddle DL, Thacker LR. Interventions associated with an increased or decreased likelihood of pain reduction and improved function in patients with adhesive capsulitis: a retrospective cohort study. Phys Ther. 2009 May;89(5):419-29. doi: 10.2522/ptj.20080250. Epub 2009 Mar 6.

Reference Type BACKGROUND
PMID: 19270045 (View on PubMed)

Kelley MJ, McClure PW, Leggin BG. Frozen shoulder: evidence and a proposed model guiding rehabilitation. J Orthop Sports Phys Ther. 2009 Feb;39(2):135-48. doi: 10.2519/jospt.2009.2916.

Reference Type BACKGROUND
PMID: 19194024 (View on PubMed)

Lee HJ, Lim KB, Kim DY, Lee KT. Randomized controlled trial for efficacy of intra-articular injection for adhesive capsulitis: ultrasonography-guided versus blind technique. Arch Phys Med Rehabil. 2009 Dec;90(12):1997-2002. doi: 10.1016/j.apmr.2009.07.025.

Reference Type BACKGROUND
PMID: 19969160 (View on PubMed)

Maricar N, Shacklady C, McLoughlin L. Effect of Maitland mobilization and exercises for the treatment of shoulder adhesive capsulitis: a single-case design. Physiother Theory Pract. 2009 Apr;25(3):203-17. doi: 10.1080/09593980902776654.

Reference Type BACKGROUND
PMID: 19384739 (View on PubMed)

Maund E, Craig D, Suekarran S, Neilson A, Wright K, Brealey S, Dennis L, Goodchild L, Hanchard N, Rangan A, Richardson G, Robertson J, McDaid C. Management of frozen shoulder: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2012;16(11):1-264. doi: 10.3310/hta16110.

Reference Type BACKGROUND
PMID: 22405512 (View on PubMed)

Michener LA, McClure PW, Sennett BJ. American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form, patient self-report section: reliability, validity, and responsiveness. J Shoulder Elbow Surg. 2002 Nov-Dec;11(6):587-94. doi: 10.1067/mse.2002.127096.

Reference Type BACKGROUND
PMID: 12469084 (View on PubMed)

Paul A, Rajkumar JS, Peter S, Lambert L. Effectiveness of sustained stretching of the inferior capsule in the management of a frozen shoulder. Clin Orthop Relat Res. 2014 Jul;472(7):2262-8. doi: 10.1007/s11999-014-3581-2. Epub 2014 Mar 25.

Reference Type BACKGROUND
PMID: 24664198 (View on PubMed)

Vastamaki H, Kettunen J, Vastamaki M. The natural history of idiopathic frozen shoulder: a 2- to 27-year followup study. Clin Orthop Relat Res. 2012 Apr;470(4):1133-43. doi: 10.1007/s11999-011-2176-4. Epub 2011 Nov 17.

Reference Type BACKGROUND
PMID: 22090356 (View on PubMed)

Waszczykowski M, Fabis J. The results of arthroscopic capsular release in the treatment of frozen shoulder - two-year follow-up. Ortop Traumatol Rehabil. 2010 May-Jun;12(3):216-24. English, Polish.

Reference Type BACKGROUND
PMID: 20675863 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014P001688

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dose Efficacy in Adhesive Capsulitis
NCT06848374 RECRUITING PHASE3